SunHo BioTech Group Ltd filed a Form F-1 registration statement for an initial public offering on 2025-09-11. It has amended it 3 times. As of its latest filing, on 2026-01-22, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We intend to list our Class A Ordinary Shares on the NYSE American under the symbol “SGSH.” The closing of this offering is conditioned upon NYSE American’s final approval of our listing application, and there is no guarantee or assurance that our Class A Ordinary Shares will be approved for listing on NYSE American.From the F-1/A filed 2026-01-22
Use of proceeds
We intend to use the net proceeds from this Offering for mergers and acquisitions (the Company has not identified any target as of the date of this prospectus); research and development, such as enhancement of R&D equipment; marketing; and operations and general working capital .From the F-1/A filed 2026-01-22
Revenue
Revenue increased by S$2,529,068 or 197% to S$3,810,202 for the six months ended June 30, 2025.From the F-1/A filed 2026-01-22
Net loss or income
For the years ended December 31, 2024, the Company reported net losses of S$2,770,705 (2023:From the F-1/A filed 2026-01-22
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-09-11 | Registration statement filed (foreign issuer) | F-1 |
| 2025-10-31 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-12-15 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-01-22 | Registration statement amended (foreign issuer) | F-1/A |
Tools for this story
Each opens in a new tab, filled in for SunHo BioTech Group Ltd. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.